Treatment timing in localized high-risk prostate cancer treated with radiation and androgen deprivation therapy

被引：0
|
作者：
Hasan, Shaakir
Lazarev, Stanislav
Gorovets, Daniel
Garg, Madhur
Press, Robert H.
Choi, Isabelle
Simone, Charles B.
机构：
[1] New York Proton Ctr, New York, NY USA
[2] Mt Sinai Med Ctr, New York, NY 10029 USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
[5] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
359
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancer
    Lee, Tae Hoon
    Pyo, Hongryull
    Yoo, Gyu Sang
    Jeon, Seong Soo
    Seo, Seong Il
    Jeong, Byong Chang
    Jeon, Hwang Gyun
    Sung, Hyun Hwan
    Kang, Minyong
    Song, Wan
    Chung, Jae Hoon
    Bae, Bong Kyung
    Park, Won
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2024, 68 (03) : 333 - 341
  • [2] Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients with Localized, High-Risk Prostate Cancer
    McCall, N. S.
    Liu, Y.
    Patel, S. A.
    Hershatter, B.
    Moghanaki, D.
    Godette, K. D.
    Hanasoge, S.
    Patel, P. R.
    Fischer-Valuck, B. W.
    Shelton, J. W.
    Jani, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E877 - E877
  • [3] Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients With Localized, High-Risk Prostate Cancer
    McCall, Neal S.
    Liu, Yuan
    Patel, Sagar A.
    Hershatter, Bruce
    Moghanaki, Drew
    Godette, Karen D.
    Hanasoge, Sheela
    Patel, Pretesh
    Fischer-Valuck, Benjamin W.
    Shelton, Joseph W.
    Jani, Ashesh B.
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (06)
  • [4] Feasibility of androgen-deprivation and radiation therapy with docetaxel for localized high-risk prostate cancer
    Iwamoto, Hiroaki
    Izumi, Kouji
    Mizokami, Atsushi
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2024, 13 (07) : 1324 - 1326
  • [5] Influence of Age on Treatment Outcomes in Intermediate or High-Risk Prostate Cancer Treated with Androgen Deprivation Therapy and Radiation Therapy
    Bryant, A. K.
    Kader, K.
    Mckay, R.
    Einck, J. P.
    Parsons, J. K.
    Kane, C. J.
    Mundt, A. J., Jr.
    Murphy, J. D.
    Rose, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E103 - E103
  • [6] Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
    Iwamoto, Hiroaki
    Izumi, Kouji
    Makino, Tomoyuki
    Mizokami, Atsushi
    CANCERS, 2022, 14 (07)
  • [7] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Cagney, Daniel N.
    Dunne, Mary
    O'Shea, Carmel
    Finn, Marie
    Noone, Emma
    Sheehan, Martina
    McDonagh, Lesley
    O'Sullivan, Lydia
    Thirion, Pierre
    Armstrong, John
    BMC UROLOGY, 2017, 17
  • [8] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Daniel N. Cagney
    Mary Dunne
    Carmel O’Shea
    Marie Finn
    Emma Noone
    Martina Sheehan
    Lesley McDonagh
    Lydia O’Sullivan
    Pierre Thirion
    John Armstrong
    BMC Urology, 17
  • [9] Impact of therapy on cancer metabolism in high-risk localized prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy
    Qu, Feng
    Gu, Yue
    Xue, Mengxia
    He, Mingzhe
    Zhou, Fang
    Wang, Guangji
    Peng, Ying
    PROSTATE, 2021, 81 (09): : 560 - 571
  • [10] Androgen Deprivation Therapy in High-Risk Prostate Cancer
    Buyyounouski, Mark K.
    ONCOLOGY-NEW YORK, 2010, 24 (09): : 806 - 809
12345